title: Contrast-enhanced spectral mammography (CESM) versus MRI in the high-risk screening setting: patient preferences and attitudes.
abstract: OBJECTIVE
  Our study evaluates patient preferences toward screening CESM versus MRI.
  
  
  METHODS
  As part of a prospective study, high-risk patients had breast MRI and CESM. Patients completed an anonymous survey to evaluate preferences regarding the two modalities.
  
  
  RESULTS
  88% of participants completed the survey. 79% preferred CESM over MRI if the exams had equal sensitivity. 89% would be comfortable receiving contrast as part of an annual screening test.
  
  
  CONCLUSIONS
  High-risk populations may accept CESM as a screening exam and may prefer it over screening MRI if ongoing trials demonstrate screening CESM to be clinically non-inferior MRI.
authors.affiliation: Department of Radiology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA. Electronic address: jphilli2@bidmc.harvard.edu.
authors.forename: Jordana
authors.initials: J
authors.lastname: Phillips
authors.affiliation: Department of Radiology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA. Electronic address: matthew.miller@duke.edu.
authors.forename: Matthew M
authors.initials: MM
authors.lastname: Miller
authors.affiliation: Department of Radiology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA. Electronic address: Tmehta@bidmc.harvard.edu.
authors.forename: Tejas S
authors.initials: TS
authors.lastname: Mehta
authors.affiliation: Department of Radiology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA. Electronic address: vfeinzac@bidmc.harvard.edu.
authors.forename: Valerie
authors.initials: V
authors.lastname: Fein-Zachary
authors.affiliation: Clinical Research Center, Gryzmish 800, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA. Electronic address: anathans@bidmc.harvard.edu.
authors.forename: Audrey
authors.initials: A
authors.lastname: Nathanson
authors.affiliation: Clinical Research Center, Gryzmish 800, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA. Electronic address: whori@bidmc.harvard.edu.
authors.forename: Wendy
authors.initials: W
authors.lastname: Hori
authors.affiliation: Clinical Research Center, Gryzmish 800, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA. Electronic address: rmonahan@bidmc.harvard.edu.
authors.forename: Rita
authors.initials: R
authors.lastname: Monahan-Earley
authors.affiliation: Department of Radiology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA. Electronic address: pslanetz@bidmc.harvard.edu.
authors.forename: Priscilla J
authors.initials: PJ
authors.lastname: Slanetz
mesh_terms: D001294:Attitude to Health; D001943:Breast Neoplasms / Q000000981:diagnostic imaging*; D003287:Contrast Media; D055088:Early Detection of Cancer; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008327:Mammography / Q000379:methods*; D008403:Mass Screening; D008875:Middle Aged; D057240:Patient Preference; D011446:Prospective Studies; D012680:Sensitivity and Specificity
chemical_list: D003287:Contrast Media
keywords: Breast cancer; Contrast-enhanced breast magnetic resonance imaging; Contrast-enhanced spectral mammography; High-risk screening